Context-Dependent Redox Mechanisms in Drug-Induced Liver Injury: Shared and Distinct Roles Across Hepatocellular and Cholestatic Phenotypes
Open Access
- 1 November 2026
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1410
Abstract
Oxidative stress and redox dysregulation are widely implicated in drug-induced liver injury (DILI), yet their roles vary considerably according to the initiating insult, cellular context, and stage of injury. Rather than representing a single pathogenic mechanism, redox disturbances may function as initiating contributors, injury amplifiers, adaptive responses, or downstream consequences of tissue injury. This review examines these context-dependent roles using hepatocellular and cholestatic DILI as complementary settings for distinguishing shared and divergent redox mechanisms. We discuss how mitochondrial oxidant stress, glutathione- and thioredoxin-dependent defenses, nuclear factor erythroid 2-related factor 2 (NRF2)-mediated adaptation, redox-sensitive signaling, lipid peroxidation, and inflammatory oxidants occupy different positions within the injury cascade across representative DILI settings. This review focuses particularly on the sources, spatial organization, timing, molecular targets, and consequences of redox events, all of which are considered together with their magnitude. This perspective may help reconcile apparently inconsistent findings across experimental models and improve the mechanistic interpretation of redox biomarkers and therapeutic interventions in DILI.Keywords
Funding Information
- National Research Foundation of Korea (RS-2022-NR070845)
- National Research Foundation of Korea (RS-2022-NR071804)
- Sookmyung Women's University (3-2403-0001)
This publication has 84 references indexed in Scilit:
- Mechanisms of drug induced liver injuryCellular and Molecular Life Sciences, 2025
- Cell-based approaches for the mechanistic understanding of drug-induced cholestatic liver injuryArchives of Toxicology, 2025
- AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injuryHepatology, 2023
- N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failureCochrane Database of Systematic Reviews, 2020
- Drug induced liver injury: an updateArchives of Toxicology, 2020
- Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium PerspectiveClinical Pharmacology & Therapeutics, 2018
- Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effortHepatology, 2018
- Omics-based responses induced by bosentan in human hepatoma HepaRG cell culturesArchives of Toxicology, 2018
- Mitogen-activated protein kinases are involved in hepatocanalicular dysfunction and cholestasis induced by oxidative stressArchives of Toxicology, 2016
- Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cellsHepatology, 2012